Why 4/5: Directs the Board of Medicine to amend regulations, impacting how providers offer opioid use disorder treatment.
This bill will require providers offering office-based buprenorphine treatment for opioid use disorder to offer counseling or referrals to counseling to their patients. Patients can refuse counseling without losing access to their buprenorphine treatment, ensuring comprehensive care options are presented while respecting patient choice.
First reading
Read first time
Referred to committee
Referred to Committee on Health and Human Services
Cleared committee
Reported from Health and Human Services (21-Y 0-N)
Second reading
Read second time
Third reading
Read third time
Passed a chamber
Passed House (98-Y 0-N 0-A)
Enrolled
Enrolled
Passed a chamber
Bill text as passed Senate and House (SB641ER)
Passed a chamber
Signed by Speaker
This bill has passed its votes and is headed to the Governor's desk. You still have a say — the Governor's office reads messages before deciding whether to sign.
New to all this? See how a bill becomes law →
Summarized from the official bill text (“Office-based buprenorphine treatment; Board of Medicine to amend regulations.”) · Read the actual bill →
Passed a chamber
Signed by President
Update
Fiscal Impact statement From DPB (3/2/2026 2:20 pm)
Enrolled
Enrolled Bill communicated to Governor on March 10, 2026
Sent to the Governor
Governor's Action Deadline 11:59 p.m., April 13, 2026
Signed into law
Approved by Governor-Chapter 208 (effective 7/1/2026)
Update
Acts of Assembly Chapter text (CHAP0208)